Trial · NCT05885737
Adverse events264
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 264
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Hyperkalaemia | Metabolism and nutrition disorders | DB Period: Difelikefalin | 21 | 129 | 27 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | DB Period: Placebo | 21 | 130 | 25 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | OLE Period: Difelikefalin/Difelikefalin | 20 | 103 | 32 |
| other | Hyperkalaemia | Metabolism and nutrition disorders | OLE Period: Placebo/Difelikefalin | 21 | 113 | 34 |
| other | Hypocalcaemia | Metabolism and nutrition disorders | DB Period: Difelikefalin | 3 | 129 | 3 |
| other | Hypocalcaemia | Metabolism and nutrition disorders | DB Period: Placebo | 2 | 130 | 3 |
| other | Hypocalcaemia | Metabolism and nutrition disorders | OLE Period: Difelikefalin/Difelikefalin | 7 | 103 | 7 |
| other | Hypocalcaemia | Metabolism and nutrition disorders | OLE Period: Placebo/Difelikefalin | 2 | 113 | 2 |
| other | Hypercalcaemia | Metabolism and nutrition disorders | DB Period: Difelikefalin | 2 | 129 | 2 |
| other | Hypercalcaemia | Metabolism and nutrition disorders | DB Period: Placebo | 1 | 130 | 1 |
| other | Hypercalcaemia | Metabolism and nutrition disorders | OLE Period: Difelikefalin/Difelikefalin | 5 | 103 | 5 |
| other | Hypercalcaemia | Metabolism and nutrition disorders | OLE Period: Placebo/Difelikefalin | 6 | 113 | 6 |
| other | Dialysis hypotension | Vascular disorders | DB Period: Difelikefalin | 19 | 129 | 71 |
| other | Dialysis hypotension | Vascular disorders | DB Period: Placebo | 9 | 130 | 26 |
| other | Dialysis hypotension | Vascular disorders | OLE Period: Difelikefalin/Difelikefalin | 13 | 103 | 55 |
| other | Dialysis hypotension | Vascular disorders | OLE Period: Placebo/Difelikefalin | 16 | 113 | 63 |
| other | Hypotension | Vascular disorders | DB Period: Difelikefalin | 21 | 129 | 29 |
| other | Hypotension | Vascular disorders | DB Period: Placebo | 8 | 130 | 11 |
| other | Hypotension | Vascular disorders | OLE Period: Difelikefalin/Difelikefalin | 11 | 103 | 12 |
| other | Hypotension | Vascular disorders | OLE Period: Placebo/Difelikefalin | 15 | 113 | 28 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05885737/events